On the Pulse | Five Myths About Obesity and New Weight Loss Medications

A Series of Physician Speakers
April 17, 2024
purple waves image
04/17/2024 12:00

Until On the Pulse | Five Myths About Obesity and New Weight Loss Medications Begins

Event Details:

Join us for our series of free, virtual presentations from physician leaders in research and care at the Minneapolis Heart Institute Foundation® (MHIF) and the Allina Health Minneapolis Heart Institute® (AHMHI) who will address the latest in cardiovascular treatment and advancements.

According to the National Institutes of Health (NIH) more than 2 in 5 adults (42.4%) have obesity. Prescription weight loss medications, such as GLP-1 agonists, have shown promising results in treating obesity and cardiovascular disease. In a recent study conducted by the Association of American Medical Colleges (AAMC), it was found that 89% of surveyed physicians have observed a recent uptick in patients requesting weight-loss medications. Despite significant attention in the media and online, it's important to note that myths still exist regarding this type of medication and obesity.

Join this On the Pulse session to learn more about:

  • The myths surrounding obesity and the new weight loss medications
  • The research behind GLP-1 agonists (including cardiovascular effects)
  • How this medicine works, what it treats, and who they are prescribed to
  • Side effects, cost, and the importance of healthy nutrition and lifestyle
  • And more!
Meet our Presenter:
An image of Dr. Michael Miedema

Michael Miedema, MD, MPH

Director, Cardiovascular Prevention | Allina Health Minneapolis Heart Institute
Director, Nolan Family Center for Cardiovascular Health | Minneapolis Heart Institute Foundation


Please contact us: email education@mhif.org or call 612-863-3625

Interested in viewing our past On the Pulse webinars?

Click here to view the recordings

Matching Gift Challenge

On the Pulse is made possible thanks to generous donors who invest in life-changing heart research and education. The Otto Bremer Trust has generously offered a challenge grant—matching all gifts dedicated to On the Pulse. We are grateful to Otto Bremer Trust for their commitment to heart-healthy living through education and awareness. Join this community of supporters and double your impact with a matched gift today!

Make a matched gift

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.